About: Gemcitabine Hydrochloride     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : owl:Class, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:label
  • Gemcitabine Hydrochloride
rdfs:subClassOf
Has_Free_Acid_Or_Base_Form
Concept_In_Subset
Semantic_Type
  • Pharmacologic Substance
  • Nucleic Acid, Nucleoside, or Nucleotide
Preferred_Name
  • Gemcitabine Hydrochloride
NSC_Code
  • 613327
UMLS_CUI
  • C0771488
CAS_Registry
  • 122111-03-9
Accepted_Therapeutic_Use_For
  • Bladder cancer; Breast cancer; Carcinoma of unknown primary origin; Lung cancer; including non-small cell lung cancer; Ovarian cancer; Pancreatic cancer; Renal cell carcinoma
In_Clinical_Trial_For
  • Ovarian cancer; Osteosarcoma; Pancreatic cancer; Renal cell cancer; Salivary Gland cancer
  • Adult Hodgkin's lymphoma; Bladder cancer; Breast Cancer; Cervical cancer; Chondrosarcoma; Ewing's sarcoma; Gallbladder cancer; Non-small cell lung cancer; Liver cancer; Meningeal Neoplasms; Mesothelioma
FDA_UNII_Code
  • U347PV74IL
Contributing_Source
  • FDA
ALT_DEFINITION
  • A drug used to treat pancreatic cancer that is advanced or has spread. It is also used with other drugs to treat breast cancer that has spread, advanced ovarian cancer, and non-small cell lung cancer that is advanced or has spread. It is also being studied in the treatment of other types of cancer. Gemcitabine hydrochloride blocks the cell from making DNA and may kill cancer cells.NCI-GLOSS
PDQ_Open_Trial_Search_ID
  • 41213
PDQ_Closed_Trial_Search_ID
  • 41213
Chemical_Formula
  • C9H11F2N3O4.HCl
Legacy_Concept_Name
  • Gemcitabine
CHEBI_ID
  • CHEBI:31647
FULL_SYN
  • 2'Deoxy-2',2'-Difluorocytidine, HydrochlorideSNNCI
  • gemcitabine hydrochloridePTNCI-GLOSSCDR0000508951
  • Gemcitabine HydrochloridePTNCI
  • Difluorodeoxycytidine HydrochlorideSYNCI
  • GemzarPTNCI-GLOSSCDR0000508952
  • dFdCydSYNCI
  • GemzarBRNCI
  • GEMCITABINE HYDROCHLORIDEPTFDAU347PV74IL
  • 1-(2-Oxo-4-amino-1,2-dihydropyrimidin-1-yl)-2-deoxy-2,2-difluororibose, hydrochlorideSNNCI
  • LY-188011CNNCI
DEFINITION
  • The hydrochloride salt of an analogue of the antimetabolite nucleoside deoxycytidine with antineoplastic activity. Gemcitabine is converted intracellularly to the active metabolites difluorodeoxycytidine di- and triphosphate (dFdCDP, dFdCTP). dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis; dFdCTP is incorporated into DNA, resulting in DNA strand termination and apoptosis.NCI
code
  • C961
is someValuesFrom of
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software